Urologix Company Description

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States.

The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort.

It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms.

It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.

Urologix, Inc.

Country	United States
Founded	1991
Industry	Medical Devices
Sector	Healthcare
Employees	61
CEO	Bryon Merade

Contact Details

Address: 14405 21st Avenue North Minneapolis, Minnesota 55447 United States
Phone	763 475 1400
Website	urologix.com

Stock Details

Ticker Symbol	ULGX
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	July - June
Reporting Currency	USD
ISIN Number	US9172731047
SIC Code	3845

Key Executives

Name	Position
Bryon Merade	Chairman and Chief Executive Officer